A Study to Assess the Effects of Zigakibart on IgA Nephropathy.

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The purpose of the study is to assess the effect of zigakibart on IgA nephropathy (IgAN) disease progression.
Epistemonikos ID: 2889b75211a58ed3e2a58de483e50efd922dfad7
First added on: Aug 29, 2025